Your Partner In Health, Sara Yadlowsky, FMHC
Some key patterns from clinical research and patient reports: Musculoskeletal effects tend to be dose-dependent across all medications Side effects typically emerge during dose escalation periods Most symptoms improve over time with continued treatment Management strategies (hydration, electrolytes, etc.) are similar across all GLP-1 medications The benefit-risk profile for each medication should be discussed with your healthcare provider, considering your specific health needs, weight loss goals, and side effect concerns
Exp Mol Med (2016) 48(3):e221
Through the Medicare GLP-1 Bridge, eligible beneficiaries can access certain GLP-1 medications for weight management for just a $50 monthly copay
The primary endpoint was major adverse cardiovascular events (MACE), defined as cardiovascular death, nonfatal heart attack, or nonfatal stroke
Heres our take: Theyre both winners, but they shine in different situations